Physician profile
Dmitriy Bronfman
NPI 1811060643
$398.75
in general payments reported to CMS, 2019-2025
9 companies · $85.36 in 2025
The $85.36 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.18 · 2021: $78.25 · 2022: $24.00 · 2023: $37.17 · 2024: $139 · 2025: $85.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $144.23 | 2021-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $66.32 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $39.34 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $34.16 | 2023-2025 | |
| Becton, Dickinson and Company | $33.82 | 2021 | |
| Shield Therapeutics INC | $22.04 | 2024 | |
| Exeltis, USA INC. | $20.02 | 2021 | |
| Allergan, INC. | $19.84 | 2019 | |
| Astellas Pharma US INC | $18.98 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Bronfman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.